E. Hyun, P. Andrade-gordon, and M. Steinhoff, Protease-activated receptor-2 activation: a major actor in intestinal inflammation, Gut, vol.57, issue.9, pp.1222-1229, 2008.
DOI : 10.1136/gut.2008.150722

N. Vergnolle, L. Cellars, and A. Mencarelli, A role for proteinase-activated receptor-1 in inflammatory bowel diseases, Journal of Clinical Investigation, vol.116, issue.7, pp.1444-1456, 2004.
DOI : 10.1172/JCI21689R1

N. Vergnolle, CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT, Gut, vol.54, issue.6, pp.867-874, 2005.
DOI : 10.1136/gut.2004.048876

N. Vergnolle, Proteinase-activated receptors (PARs) in infection and inflammation in the gut, The International Journal of Biochemistry & Cell Biology, vol.40, issue.6-7, pp.1219-1227, 2008.
DOI : 10.1016/j.biocel.2008.01.016

N. Cenac, C. Andrews, and M. Holzhausen, Role for protease activity in visceral pain in irritable bowel syndrome, Journal of Clinical Investigation, vol.117, issue.3, pp.636-647, 2007.
DOI : 10.1172/JCI29255

M. Hornsby, J. Huff, and R. Kays, Helicobacter pylori Induces an Antimicrobial Response in Rhesus Macaques in a cag Pathogenicity Island-Dependent Manner, Gastroenterology, vol.134, issue.4, pp.1049-1057, 2008.
DOI : 10.1053/j.gastro.2008.01.018

H. Molhuizen, H. Alkemade, and P. Zeeuwen, SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking, J Biol Chem, vol.268, pp.12028-12032, 1993.

J. Sallenave and A. Ryle, Purifkation and Characterization of Elastase-Specific Inhibitor. Sequence Homology with Mucus Proteinase Inhibitor, Biological Chemistry Hoppe-Seyler, vol.372, issue.1, pp.13-21, 1991.
DOI : 10.1515/bchm3.1991.372.1.13

J. Sallenave, Secretory Leukocyte Protease Inhibitor and Elafin/Trappin-2, American Journal of Respiratory Cell and Molecular Biology, vol.42, issue.6, pp.635-643, 2010.
DOI : 10.1165/rcmb.2010-0095RT

G. Tremblay, J. Sallenave, and E. Israel-assayag, Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung., American Journal of Respiratory and Critical Care Medicine, vol.154, issue.4, pp.1092-1098, 1996.
DOI : 10.1164/ajrccm.154.4.8887613

Z. Wang, F. Chen, and R. Zhai, Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development, PLoS ONE, vol.13, issue.3, p.4380, 2009.
DOI : 10.1371/journal.pone.0004380.s005

URL : http://doi.org/10.1371/journal.pone.0004380

O. Wiedow, J. Luademann, and B. Utecht, Elafin is a potent inhibitor of proteinase 3, Biochemical and Biophysical Research Communications, vol.174, issue.1, pp.6-10, 1991.
DOI : 10.1016/0006-291X(91)90476-N

M. Schmid, K. Fellermann, and P. Fritz, Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease, Journal of Leukocyte Biology, vol.81, issue.4, pp.907-915, 2007.
DOI : 10.1189/jlb.0906581

J. Sallenave, Z. Xing, and A. Simpson, Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters, Gene Therapy, vol.5, issue.3, pp.352-360, 1998.
DOI : 10.1038/sj.gt.3300610

K. Kessenbrock, L. Frohlich, and M. Sixt, Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin, Journal of Clinical Investigation, vol.118, pp.2438-2447, 2008.
DOI : 10.1172/JCI34694DS1

J. Sallenave, G. Cunningham, and R. James, Regulation of Pulmonary and Systemic Bacterial Lipopolysaccharide Responses in Transgenic Mice Expressing Human Elafin, Infection and Immunity, vol.71, issue.7, pp.3766-3774, 2003.
DOI : 10.1128/IAI.71.7.3766-3774.2003

S. Zaidi, C. Hui, and A. Cheah, Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis, Journal of Clinical Investigation, vol.103, issue.8, pp.1211-1219, 1999.
DOI : 10.1172/JCI5099

F. Cattaruzza, N. Cenac, and E. Barocelli, Protective Effect of Proteinase-Activated Receptor 2 Activation on Motility Impairment and Tissue Damage Induced by Intestinal Ischemia/Reperfusion in Rodents, The American Journal of Pathology, vol.169, issue.1, pp.177-188, 2006.
DOI : 10.2353/ajpath.2006.051098

N. Cenac, A. Coelho, and C. Nguyen, Induction of Intestinal Inflammation in Mouse by Activation of Proteinase-Activated Receptor-2, The American Journal of Pathology, vol.161, issue.5, pp.1903-1915, 2002.
DOI : 10.1016/S0002-9440(10)64466-5

N. Cenac, L. Cellars, and M. Steinhoff, Proteinase-activated Receptor-1 is an Anti-Inflammatory Signal for Colitis Mediated by a Type 2 Immune Response, Inflammatory Bowel Diseases, vol.11, issue.9, pp.792-798, 2005.
DOI : 10.1097/01.mib.0000177506.71784.bd

K. Hansen, P. Sherman, and L. Cellars, A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis, Proceedings of the National Academy of Sciences, vol.102, issue.23, pp.8363-8368, 2005.
DOI : 10.1073/pnas.0409535102

N. Cenac, A. Chin, and R. Garcia-villar, activation alters colonic paracellular permeability in mice via IFN-??-dependent and -independent pathways, The Journal of Physiology, vol.6, issue.3, pp.913-925, 2004.
DOI : 10.1113/jphysiol.2004.061721

A. Chin, N. Vergnolle, and W. Macnaughton, Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability, Proceedings of the National Academy of Sciences, vol.100, issue.19, pp.11104-11109, 2003.
DOI : 10.1073/pnas.1831452100

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC196934

T. Piche, G. Barbara, and A. P. , Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators, Gut, vol.58, issue.2, pp.196-201, 2009.
DOI : 10.1136/gut.2007.140806

URL : https://hal.archives-ouvertes.fr/inserm-00332066

M. Butler, I. Robertson, and C. Greene, Elafin Prevents Lipopolysaccharide-induced AP-1 and NF-??B Activation via an Effect on the Ubiquitin-Proteasome Pathway, Journal of Biological Chemistry, vol.281, issue.46, pp.34730-34735, 2006.
DOI : 10.1074/jbc.M604844200

P. Henriksen, M. Hitt, and Z. Xing, Adenoviral Gene Delivery of Elafin and Secretory Leukocyte Protease Inhibitor Attenuates NF-??B-Dependent Inflammatory Responses of Human Endothelial Cells and Macrophages to Atherogenic Stimuli, The Journal of Immunology, vol.172, issue.7, pp.4535-4544, 2004.
DOI : 10.4049/jimmunol.172.7.4535

M. Pasparakis, Regulation of tissue homeostasis by NF-??B signalling: implications for inflammatory diseases, Nature Reviews Immunology, vol.54, issue.11, pp.778-788, 2009.
DOI : 10.1038/nri2655

A. Simpson, A. Maxwell, and J. Govan, Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens, FEBS Letters, vol.162, issue.3, pp.309-313, 1999.
DOI : 10.1016/S0014-5793(99)00670-5

R. Sartor, Microbial Influences in Inflammatory Bowel Diseases, Gastroenterology, vol.134, issue.2, pp.577-594, 2008.
DOI : 10.1053/j.gastro.2007.11.059

M. Laukoetter, P. Nava, and A. Nusrat, Role of the intestinal barrier in inflammatory bowel disease, World Journal of Gastroenterology, vol.14, issue.3, pp.401-407, 2008.
DOI : 10.3748/wjg.14.401

J. Wehkamp, N. Salzman, and E. Porter, Reduced Paneth cell ??-defensins in ileal Crohn's disease, Proceedings of the National Academy of Sciences, vol.102, issue.50, pp.18129-18134, 2005.
DOI : 10.1073/pnas.0505256102